Prevalence of HTLV III/LAV and other viral antibodies in normal and at risk populations.
The prevalence of HTLV III/LAV antibody has been studied in six groups of population: healthy subjects, a virological laboratory staff, prisoners, drug addicts, patients with lymphoadenopathy-associated syndrome (LAS) and patients with AIDS. Prevalences and levels in the same groups of HBsAg and CMV, HSV 1 and HSV 2 antibodies have been studied, too. As expected, the prevalence of HTLV III/LAV antibody increases in the six groups with the increasing of the risk while the prevalences of the other markers of viral infection do not show such a pattern. The levels of positivity of CMV antibody are significantly higher in the prisoners and LAS groups versus healthy subjects suggesting a possible role of this virus in the developing of full-blown AIDS.
D000386:AIDS-Related Complex / Q000276:immunology*; D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology*; D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis*; D003587:Cytomegalovirus / Q000276:immunology; D006678:HIV / Q000276:immunology*; D006801:Humans; D012306:Risk
D000914:Antibodies, Viral